Medical genetics and epigenetics of telomerase.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology
PubMed 21323862 · doi:10.1111/j.1582-4934.2011.01276.x
What was done
This narrative review summarizes literature on the genetic and epigenetic regulation of telomerase. It describes mechanisms involving non-coding RNAs (including microRNAs and telomeric-repeat containing RNA transcripts), single nucleotide polymorphisms, and mutations in telomerase subunit genes linked to human genetic disorders.
What was found
The abstract reports no numerical findings, effect sizes, or quantitative data. It qualitatively summarizes how genetic variations, mutations, and non-coding RNAs influence telomerase activity and related disease pathways.
Why it matters
Clarifying the genetic and epigenetic factors controlling telomerase informs ongoing research into potential therapeutic modulation of telomerase activity in medicine.
Limits
The abstract contains no primary data, sample sizes, or systematic review methodology. It relies on qualitative, mechanism-based descriptions without quantitative clinical or epidemiological outcomes.
Cited by
- supports Telomerase is an intracellular RNA reverse transcriptase that rebuilds telomeres, and knocking it down stops cell division while upregulating it immortalizes cells.